EUVIMEDObjevte EUVIMED
Open access · CC BY 4.0

Copy Number Gains of VPS72 Drive De Novo Lipogenesis and Hepatocarcinogenesis via ATF3/mTORC1/SREBP1 Axis

Qinglin Zhang iD, Yunxing Huang, Yin Tong, Kenneth Tsz Chun Ng, Jiangwen Zhang iD

Advanced Science · 2025

DOI: 10.1002/advs.202411368 ↗

At a glance

Journal article in Advanced Science, 2025. Written by Qinglin Zhang and 4 co-authors. Institution: School of Biological Sciences, The University of Hong Kong, Hong Kong, SAR, 999077, China. Major MEDLINE topics: Liver Neoplasms, Carcinoma, Hepatocellular, Mechanistic Target of Rapamycin Complex 1, Lipogenesis. Cited 3 times so far (Crossref); 51 references. The full text is freely available (open access, CC BY 4.0). Funded by: Research Grants Council of Hong Kong China, National Natural Science Foundation of China.

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

Hepatocellular carcinoma (HCC) is the predominant form of primary liver cancer and a major contributor to cancer‐related mortality globally. Central to its pathogenesis is the dysregulation of lipid metabolism in hepatocytes, leading to abnormal lipid accumulation. Our bioinformatics analysis has identified the histone acetyltransferase complex subunit VPS72 as being associated with HCC, yet the precise molecular mechanisms through which VPS72 contributes to hepatocarcinogenesis remain poorly understood. Our analysis of extensive HCC patient cohorts identifies a significant proportion with VPS72 copy number gains, which are strongly linked to adverse prognostic outcomes. By integrating RNA‐Seq, ChIP‐Seq, ATAC‐seq, and experimental validation, we show that VPS72 overexpression activates mTORC1 signaling, subsequently promoting lipid synthesis and driving HCC progression. We further uncover that VPS72 modulates the epigenetic landscape by enhancing DNA methylation at the ATF3 promoter, resulting in ATF3 repression and subsequent activation of mTORC1. This study elucidates a novel regulatory axis that links dysregulated lipid metabolism with HCC progression, highlighting potential epigenetic and metabolic targets for therapeutic intervention.

Subjects

MeSH terms (MEDLINE)

Liver NeoplasmsCarcinoma, HepatocellularMechanistic Target of Rapamycin Complex 1LipogenesisActivating Transcription Factor 3Sterol Regulatory Element Binding Protein 1CarcinogenesisVesicular Transport ProteinsHumansSignal TransductionCell Line, TumorGene Expression Regulation, NeoplasticDNA Copy Number VariationsAnimals

Author keywords

epigenetics regulationlipid metabolismmTORC1 signaling

Substances

Mechanistic Target of Rapamycin Complex 1Activating Transcription Factor 3Sterol Regulatory Element Binding Protein 1ATF3 protein, humanSREBF1 protein, humanVesicular Transport Proteins

Authors and institutions

  • School of Biological Sciences, The University of Hong Kong, Hong Kong, SAR, 999077, China.
  • Department of Pathology, School of Clinical Medicine, The University of Hong Kong, Queen Mary Hospital, Pokfulam, Hong Kong, SAR, 999077, China.
  • Centre for Oncology and Immunology, Hong Kong Science Park, Hong Kong, SAR, 999077, China.

ORCID profiles: Qinglin Zhang, Jiangwen Zhang

Funding

  • Research Grants Council of Hong Kong China
  • National Natural Science Foundation of China

Cite

APA

Zhang, Q., Huang, Y., Tong, Y., Ng, K. T. C., & Zhang, J. (2025). Copy Number Gains of VPS72 Drive De Novo Lipogenesis and Hepatocarcinogenesis via ATF3/mTORC1/SREBP1 Axis. Advanced Science. https://doi.org/10.1002/advs.202411368

Vancouver

Zhang Q, Huang Y, Tong Y, Ng KTC, Zhang J. Copy Number Gains of VPS72 Drive De Novo Lipogenesis and Hepatocarcinogenesis via ATF3/mTORC1/SREBP1 Axis. Advanced Science. 2025. doi:10.1002/advs.202411368

BibTeX
@article{Zhang2025,
  author = {Zhang, Qinglin and Huang, Yunxing and Tong, Yin and Ng, Kenneth Tsz Chun and Zhang, Jiangwen},
  title = {Copy Number Gains of VPS72 Drive De Novo Lipogenesis and Hepatocarcinogenesis via ATF3/mTORC1/SREBP1 Axis},
  journal = {Advanced Science},
  year = {2025},
  doi = {10.1002/advs.202411368}
}
Start for free →